Study Reveals Real-World Impact Of Switching DMTs On Relapse Risk In MS
Switching Between MS Therapies Linked to Higher Relapse Risk, Study Finds A recent real-world study in Canada has highlighted that individuals with multiple sclerosis (MS) who switch between more than two disease-modifying therapies (DMTs) face an increased risk of relapses, irrespective of their adherence to prescribed medications. The research suggests that a greater number of…